Skip to main content

Nelarabine Injection Shortage

Last Updated: April 3, 2025
Status: Current

Products Affected - Description
    • Nelarabine injection, Sagent, 5 mg/mL, 50 mL vial, 1 count, NDC 25021-0259-50
    • Nelarabine injection, Sagent, 5 mg/mL, 50 mL vial, 6 count, NDC 25021-0259-51
    • Nelarabine injection, Zydus, 5 mg/mL, 50 mL vial, 1 count, NDC 70710-1726-01
    • Nelarabine injection, Zydus, 5 mg/mL, 50 mL vial, 6 count, NDC 70710-1726-08
Reason for the Shortage
    • Alembic has nelarabine injection available.
    • Amneal has nelarabine injection available.
    • Dr. Reddy's has nelarabine injection available.
    • Meitheal has nelarabine injection available.
    • Novadoz is shipping to forecast.
    • Sagent did not provide a reason for the shortage.
    • Sandoz has Arranon injection available.
    • Shorla Oncology has nelarabine injection available.
    • X-Gen has nelarabine injection available.
    • Zydus states the reason for the shortage is regulatory delay.
Available Products
    • Arranon injection, Sandoz, 5 mg/mL, 50 mL vial, 1 count, NDC 00078-0683-61
    • Nelarabine injection, Alembic, 5 mg/mL, 50 mL vial, 1 count, NDC 62232-0813-50
    • Nelarabine injection, Alembic, 5 mg/mL, 50 mL vial, 6 count, NDC 62232-0813-63
    • Nelarabine injection, Amneal, 5 mg/mL, 50 mL vial, 1 count, NDC 70121-1743-01
    • Nelarabine injection, Amneal, 5 mg/mL, 50 mL vial, 6 count, NDC 70121-1743-04
    • Nelarabine injection, Dr. Reddy's, 5 mg/mL, 50 mL vial, 1 count, NDC 43598-0142-11
    • Nelarabine injection, Dr. Reddy's, 5 mg/mL, 50 mL vial, 6 count, NDC 43598-0142-06
    • Nelarabine injection, Meitheal Pharmaceuticals, 5 mg/mL, 50 mL vial, 1 count, NDC 71288-0165-54
    • Nelarabine injection, Novadoz, 5 mg/mL, 50 mL vial, 1 count, NDC 72205-0154-01
    • Nelarabine injection, Novadoz, 5 mg/mL, 50 mL vial, 6 count, NDC 72205-0154-04
    • Nelarabine injection, Shorla Oncology, 5 mg/mL, 50 mL vial, 1 count, NDC 81927-0111-01
    • Nelarabine injection, Shorla Oncology, 5 mg/mL, 50 mL vial, 6 count, NDC 81927-0111-06
    • Nelarabine injection, X-Gen, 5 mg/mL, 50 mL vial, 1 count, NDC 39822-0650-01
    • Nelarabine injection, X-Gen, 5 mg/mL, 50 mL vial, 6 count, NDC 39822-0650-06

Estimated Resupply Dates

    • Sagent has nelarabine 5 mg/mL 50 mL vials in 1 count and 6 count on back order and the company estimates a release date of April 2025.
    • Zydus has nelarabine 5 mg/mL 50 mL vials on back order and the company estimates a release date in late-April 2025.

Updated

Updated April 3, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 17, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer